Diagnostic value of apparent diffusion coefficient (ADC) in evaluating hepatocellular carcinomas post trans-catheter arterial chemoembolization and radiofrequency ablation-Reference-Cited by-同舟云学术

Diagnostic value of apparent diffusion coefficient (ADC) in evaluating hepatocellular carcinomas post trans-catheter arterial chemoembolization and radiofrequency ablation

Published:2016-09 Issue:3 Volume:47 Page:699-706
ISSN:0378-603X
Container-title:The Egyptian Journal of Radiology and Nuclear Medicine
language:en
Short-container-title:The Egyptian Journal of Radiology and Nuclear Medicine

Author:

Tantawy Hazim I.,Mohamed Faten Fawzy

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging

Reference18 articles.

1. Treatment of hepatocellular carcinoma: present and future;Genco;Expert Rev. Anticancer Ther.,2013

2. Magnetic resonance imaging of the liver after loco-regional and systemic therapy;Corona-Villalobos;Magn. Reson. Imaging Clin. North Am.,2014

3. Field-practice study of sorafenib therapy for hepatocellular carcinoma: a pro-spective multicenter study in Italy;Iavarone;Hepatology,2011

4. Role of diffusion-weighted imaging in evaluating therapeutic efficacy after transcatheter arterial chemoembolization for hepatocellular carcinoma;Kubota;Oncol. Rep.,2010

5. Assessment of tumor response on MR imaging after locoregional therapy;Vossen;Tech. Vasc. Interv. Radiol.,2006

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diffusion-weighted imaging compared to dynamic MRI in early response assessment of locoregional therapy (by trans-arterial chemoembolization & microwave ablation) of hepatocellular carcinoma;Egyptian Journal of Radiology and Nuclear Medicine;2023-12-07

2. Value of dynamic and DWI MRI in evaluation of HCC viability after TACE via LI-RADS v2018 diagnostic algorithm;Egyptian Journal of Radiology and Nuclear Medicine;2019-12

3. Apparent diffusion coefficient and dynamic contrast-enhanced MRI as reliable biomarkers for evaluating response to locoregional therapy in hepatocellular carcinoma patients;The Egyptian Journal of Radiology and Nuclear Medicine;2018-12